AstraZeneca Pharma India shares will see higher activity next week, as its board of directors will meet on April 15 to consider seeking shareholders approval for delisting proposal through postal ballot. Earlier on March 15, the board had approved the proposal received from its promoter AstraZeneca Pharmaceuticals AB, Sweden. After having failed in its earlier two attempts, it would be interesting to know whether this time the company will succeed in its delisting move.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.